Ppm1d hyperactivity also seems to restrict the infiltration of tumors by antitumor neutrophils, suggesting that Ppm1d inhibition may enhance the effects of cancer immunotherapy (Uyanik et al., 2021). Here, PPM1D is linked to cancer.